GlucoSet

Trondhjem, Norway

GlucoSet is medical device company that is developing sensor technology for improved glucose control in intensive care units.

$6.6M raised

Jul 2023

Series A

Top Investors

European Innovation CouncilEASMEHorizon 2020TeleVenture ManagementSwiss Diabetes Venture Fund

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has GlucoSet raised?

GlucoSet has raised $6.6M in total funding. The most recent round was Series A. The last funding was announced in July 2023.

Who are GlucoSet's investors?

GlucoSet's investors include European Innovation Council, EASME, Horizon 2020, TeleVenture Management, Swiss Diabetes Venture Fund.

Where is GlucoSet headquartered?

GlucoSet is headquartered in Trondhjem, Norway.

What does GlucoSet do?

GlucoSet is medical device company that is developing sensor technology for improved glucose control in intensive care units.

What stage is GlucoSet at?

GlucoSet is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 7, 2023.

MLA

"GlucoSet — Funding & Investors." VCBacked, July 7, 2023, https://www.vcbacked.co/company/glucoset. Accessed June 4, 2026.

APA

VCBacked. (2023). GlucoSet — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/glucoset

Wikipedia (cite web)

{{cite web |title=GlucoSet — Funding & Investors |url=https://www.vcbacked.co/company/glucoset |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 7, 2023.